摘要
目的分析经内科胸腔镜治疗结核性胸膜炎的临床疗效。方法选择我院2014年5月~2015年5月期间收治的141例结核性胸膜炎患者的临床资料进行回顾性分析,按治疗方法不同分为治疗组71例和对照组70例,两组均使用规则抗结核治疗和激素促进胸水吸收,治疗组经内科胸腔镜分离、松解胸腔内网格状粘连、多房分隔,而对照组则采用传统彩超定位胸腔穿刺抽液或置管引流方法,分别观察两组疗效及3个月随访不良反应。结果治疗组的平均住院天数为（9.21±2.36）d,明显短于对照组的（11.94±7.16）d;并且治疗组的有效率为78.87%,明显高于对照组的57.14%,3个月随访均无不良反应,两组间差异比较均具有统计学意义（P〈0.05）。结论经内科胸腔镜治疗结核性胸膜炎较传统方法疗效显著,是治疗结核性胸膜炎安全有效的手段。
Objective To analysis the clinical efficacy of thoracoscopy in the treatment of tuberculous pleurisy by separating the intrathoracic adhesions and peeling the fibreboard. Methods The clinical data of 141 patients with tuberculous pleurisy in our hospital from May 2014 to May 2015 were retrospectively analyzed and the patients were divided into the treatment group 71 cases and control group 70 cases according to different treatment methods.Patients in treatment group received thoracoscopy and the control group were underwent pleural puncure following B-mode ultrasonography localization.The curative effect were observed and follow-up for 3 months for the adverse reactions. Results The average length of hospital stay in the treatment group was（9.21±2.36）d,significantly shorter than the（11.94±7.16）d of the control group;The effective rate of the treatment group was 78.87%,significantly higher than the 57.14% of the control group;3 months follow-up were no adverse reactions which difference between the two groups were statistically significant（P〈0.05）. Conclusion The thoracoscopy can significantly improve the clinical symptoms of tuberculous pleurisy,reduce the formation of pleural thickening,shorten the length of treatment and improve the prognosis.
出处
《中国医药科学》
2016年第5期219-221,共3页
China Medicine And Pharmacy
关键词
内科胸腔镜
结核性胸膜炎
疗效
治愈率
不良反应
Video-assisted thoracoscopic
Tuberculous pleurisy
Curative effect
Cure rate
Adverse reaction
